We aimed to assess the prognostic value of “liquid biopsies” (CTC-associated mRNA and blood-derived RNA) for the benefit of PSMA PET-guided salvage RT in oligometastatic prostate cancer relapse. This evidence concerns the gene FOLH1 and Familial prostate cancer.